Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Hua Medicine Raises $117.4m While Evaluating A Hong Kong IPO

Apr 06 2018

• By Mandy Jackson

Finance Watch

Related Content

Duchenne Muscular Dystrophy: The Race For The $1bn Opportunity

Sep 29 2017

Pipeline Watch: Kisqali, SI-6603, Cosentyx Phase III Readouts

Nov 13 2017

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

Feb 16 2018

Pipeline Watch: Phase III Progress With Eylea, Tecentriq And HTX-011

Mar 26 2018

From Inception, Tempest Plans To Kick Up IO Storm

Mar 28 2018

Battle Lines Drawn In New Renal Anemia Market

Jun 08 2017

Incyte Adds PD-1 Inhibitor To Its Promising IDO With MacroGenics Deal

Oct 26 2017

Related Companies

Hua Medicine (Shanghai) Ltd.

Tempest Therapeutics, Inc.

NMD Pharma AS

Heron Therapeutics, Inc.

Sorrento Therapeutics, Inc.

PTC Therapeutics, Inc.

MacroGenics, Inc.

Akebia Therapeutics, Inc.

EyePoint Pharmaceuticals, Inc.

Alimera Sciences Inc.

Bausch Health Companies Inc.

Zosano Pharma Corporation

Addex Therapeutics Ltd

TRACON Pharmaceuticals Inc.

Summit Therapeutics Inc.

Additional Topics

Financing Business Strategies StartUps and SMEs Deals Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window